Disease-specific overall survival in endometrioid ovarian

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study, Journal of Ovarian Research

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment - Gynecologic Oncology

Develop a nomogram to predict overall survival of patients with borderline ovarian tumors

Ovarian Cancer Survival Rate

PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair

Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors

Develop a nomogram to predict overall survival of patients with borderline ovarian tumors

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

Frontiers Systematic Lymph Node Dissection May Be Abolished in Patients With Apparent Early-Stage Low-Grade Mucinous and Endometrioid Epithelial Ovarian Cancer

Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis - Gynecologic Oncology

Novel Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Uncovered by Data-Independent Acquisition Mass Spectrometry

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome